Afya LTD 20-F annual reports

The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.

NASDAQ
Afya Limited announced robust financial results for 2025, driven by significant revenue and net income growth, strategic acquisitions, and the maturation of its medical school seats.
NASDAQ
Afya Limited releases its 20-F filing, highlighting financial performance and key business activities for the year ended December 31, 2024.
NASDAQ
Afya Limited's 20-F filing for 2023 highlights the company's financial results, strategic initiatives, and risk factors, emphasizing its position as a leading medical education group in Brazil.